New developments in the management of nonmuscle invasive bladder cancer.

about

New developments in the management of nonmuscle invasive bladder cancer.

Item

http://www.wikidata.org/entity/Q38914895

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

New developments in the management of nonmuscle invasive bladder cancer.

@en

type

Item

label

New developments in the management of nonmuscle invasive bladder cancer.

@en

prefLabel

New developments in the management of nonmuscle invasive bladder cancer.

@en

P1476

New developments in the management of nonmuscle invasive bladder cancer.

@en

P2093

Daniel Lee

http://www.w3.org/2001/XMLSchema#string

Mark D Tyson

http://www.w3.org/2001/XMLSchema#string

Peter Clark

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Car

Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies.

Natural biology and management of nonmuscle invasive bladder cancer.

A systematic review of regional hyperthermia therapy in bladder cancer.

High magnification cystoscopy in the primary diagnosis of bladder tumors.

SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin

The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.

Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies

Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin.

Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer.

P31

scholarly article

P356

10.1097/CCO.0000000000000362

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28282341

http://www.w3.org/2001/XMLSchema#string

P932

5665722

http://www.w3.org/2001/XMLSchema#string